Tyra Biosciences, Inc.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
TYRA$21.15+1.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit Number · Exhibit Description · Incorporated by Reference · Filed Herewith | |||||
|---|---|---|---|---|---|
| Form · Date · Number | |||||
| 3.1 | Amended and Restated Certificate of Incorporation | 10-K | 3/22/23 | 3.1 | |
| 3.2 | Certificate of Amendment of Amended and Restated Certificate of Incorporation, dated May 29, 2024 | 8-K | 5/31/24 | 3.1 | |
| 3.3 | Amended and Restated Bylaws, effective as of October 26, 2023 | 8-K | 10/26/23 | 3.1 | |
| 4.1 | Specimen stock certificate evidencing the shares of common stock | S-1 | 8/20/21 | 4.1 | |
| 4.2 | Amended and Restated Investors’ Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders | S-1/A | 9/9/21 | 4.2 | |
| 4.3 | Form of Pre-Funded Warrant | 8-K | 2/5/24 | 4.1 | |
| 4.4 | Form of Exchange Warrant | 8-K | 10/18/24 | 4.1 | |
| 5.1 | Opinion of Latham & Watkins LLP | X | |||
| 10.1# | Non-Employee Director Compensation Program, amended and restated effective May 28, 2026 | X | |||
| 10.2# | Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Tyra Biosciences, Inc. 2021 Incentive Award Plan | X | |||
| 10.3 | Amendment No. 1 to Sales Agreement, dated August 4, 2026, between the Registrant and TD Securities (USA) LLC | X | |||
| 31.1 | Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 31.2 | Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.1* | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 32.2* | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | |||
| 101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.